Bellevue Asset Management, LLC Omeros Corp Transaction History

Bellevue Asset Management, LLC

  • $194 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.92 - $6.28 $29,376 - $96,084
-15,300 Reduced 96.77%
511 $1.4 Million
Q4 2021

Feb 03, 2022
BUY
$5.67 - $8.54 $27,216 - $40,991
4,800 Added 43.59%
15,811 $102,000
Q1 2020

May 13, 2020
BUY
$9.03 - $19.72 $99,429 - $217,136
11,011 New
11,011 $181,000

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $762M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Bellevue Asset Management, LLC Portfolio

Follow Bellevue Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email